BackProteostasis Therapeutics Overview

Proteostasis Therapeutics Operating Income

Operating Income for PTI.

Quarterly Operating Income

$-5776000.00
56.57% YoY

As of Sep 30, 2020

Annual Operating Income (TTM)

$-36987000.00
44.37% YoY

Trailing 12 months ending Sep 30, 2020

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)